Adiumentum Capital Fund I LP reports holding 6.7% of Atara Biotherapeutics' shares as of May 15 — SEC filing
Adiumentum Capital Fund I LP报告称截至5月15日持有Atara Biotherapeutics6.7％的股份——美国证券交易委员会备案
Adiumentum Capital Fund I LP reports holding 6.7% of Atara Biotherapeutics' shares as of May 15 — SEC filing
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.